US Executive Officer Management Changes SEC — April 09, 2026

09-04-2026

Wabash National Corporation announced the transition of Michael N. Pettit from Senior Vice President, Chief Growth Officer to a non-executive Senior Advisor role effective April 8, 2026, with his employment continuing until the third quarter of 2026 to ensure a smooth handover. During this transition period, Pettit will receive continued annual base salary at $575,000, pro-rated 2026 incentive bonus eligibility, and vesting of existing equity awards, but no new grants. Upon separation, he will be eligible for severance under the Executive Severance Plan, subject to release of claims and covenant compliance.

• ·Transition Date: April 8, 2026
• ·Separation Date: Third quarter of 2026
• ·Pettit reports to Chief Executive Officer or designee as Senior Advisor
• ·No participation in Change in Control Plan post-Transition Date

09-04-2026

Treace Medical Concepts announced preliminary unaudited Q1 2026 revenue of $47.0 million to $47.2 million and cash, cash equivalents, and marketable securities of $51.9 million as of March 31, 2026, reflecting a $3.5 million QoQ increase from $48.4 million at December 31, 2025—outperforming the $0.4 million increase in Q1 2025. The company narrowed its FY2026 revenue guidance to $202 million to $212 million from the prior $200 million to $212 million range, driven by case volume growth but offset by product and price mix headwinds in its expanded bunion portfolio. Chief Commercial Officer Gaetano M. Guglielmino departs effective April 8, 2026, amicably, with responsibilities absorbed by existing staff including SVP Sales reporting to CEO John T. Treace; he will consult through January 31, 2027.

• ·Consulting agreement includes COBRA premium payments, pro-rated 2026 target bonus, apartment rent payments until lease assignment, and continued vesting of prior equity awards.
• ·Mr. Guglielmino signed a release of claims and confirmed enforceability of confidentiality, nonsolicitation, and noncompetition agreements.

09-04-2026

OptimizeRx Corp. (Nasdaq: OPRX) announced the appointment of Mary Varghese Presti, Corporate Vice President and Chief Operating Officer of Microsoft’s Health & Life Sciences organization, as an independent director to its Board of Directors on April 8, 2026. This appointment supports the company's ongoing board refresh and expansion, bringing her over 25 years of expertise in healthcare, life sciences, technology scaling, AI integration, M&A, and operational efficiency from roles at Microsoft, Nuance, IBM Watson Health, athenahealth, and Pfizer. CEO Steve Silvestro highlighted her alignment with OptimizeRx's strategy to evolve into an integrated, product-led platform with growing recurring revenue.

• ·Varghese Presti involved in Microsoft’s Nuance acquisition integration and IBM Watson Health divestiture diligence.
• ·OptimizeRx headquartered in Waltham, Massachusetts.
• ·Investor Relations contact: Andy D’Silva (adsilva@optimizerx.com); Marketing: Jennifer Dinkel (jdinkel@optimizerx.com); Press: optimizerx@matternow.com.

09-04-2026

Live Ventures Incorporated's indirect wholly-owned subsidiary, Vintage Stock Inc., amended the Employment Agreement with its President and CEO, Rodney Spriggs, effective March 31, 2026, extending the term to March 31, 2028. The Third Amendment includes a one-time cash bonus of $250,000 payable on or before April 14, 2026, and an additional 80 hours of paid time off per calendar year.

• ·Third Amendment approved by Compensation Committee via written consent
• ·Third Amendment filed as Exhibit 10.145

09-04-2026

Orthofix Medical Inc. announced a Spine leadership realignment, eliminating the President, Global Spine Solutions role, with Shaeffer Bannigan, Mark Sienkiewicz, John Winge, and Patrick Fisher assuming expanded responsibilities reporting to CEO Massimo Calafiore to accelerate growth and execution. Preliminary Q1 2026 net sales were $196.7 million (up 1.6% YoY reported, 0.4% constant currency), or $196.4 million pro forma excluding M6 discs (up 3.8% reported, 2.7% constant currency), though impacted by a 94.2% decline in discontinued M6 product lines. The company reaffirmed FY2026 guidance of $850-860 million net sales (5.5% pro forma constant currency growth at midpoint), $95-98 million adjusted EBITDA (70 bps margin expansion), and positive free cash flow.

• ·Q1 2026 earnings call and webcast scheduled for May 5, 2026, at 8:30 am ET.
• ·Participation in 25th Annual Needham Virtual Healthcare Conference on April 14, 2026.

09-04-2026

Valmont Industries, Inc. announced the appointment of John Schwietz as Executive Vice President, Chief Financial Officer, and Corporate Secretary, effective April 8, 2026, succeeding Thomas Liguori. Mr. Schwietz, 44, joined the company in 2009 and has held progressively senior roles in finance, business development, and operations, including President – International Agriculture since May 2024.

• ·Mr. Schwietz's prior roles: Vice President and General Manager – International Agriculture (August 2023 – May 2024), Vice President Finance, Global Utility and Renewable Generation (June 2021 – August 2023), Vice President, Finance Renewable Generation (January 2020 – June 2021)
• ·Event reported on April 8, 2026; filing dated April 9, 2026

09-04-2026

Blink Charging Co. elected Glen Moller to its Board of Directors effective April 7, 2026, expanding the board to five members. Mr. Moller, a 54-year-old seasoned executive and current CEO of Upward Health Inc., brings extensive leadership experience in healthcare turnarounds and scaling high-growth organizations. The board has determined that Mr. Moller is independent, with no related party transactions, arrangements, or family relationships disclosed.

• ·Mr. Moller earned a B.A. in Economics and English from Boston College and an M.B.A. from Harvard Business School.
• ·Named E&Y Entrepreneur of the Year (NY Region) in 2025.
• ·No participation in transactions with the company requiring disclosure under Item 404(a) of Regulation S-K.

09-04-2026

The Buckle, Inc. reported net sales for the 5-week fiscal month ended April 4, 2026 of $118.0 million, an increase of 8.2% from $109.1 million in the prior year period, with comparable store net sales up 7.0%. For the year-to-date 9-week period ended April 4, 2026, net sales rose 8.5% to $202.5 million from $186.6 million, and comparable store net sales increased 7.4%. The company also appointed Scott A. Werth as Senior Vice President of Stores effective March 31, 2026.

• ·Company opened one new store in Overland Park, Kansas during fiscal March.
• ·Scott A. Werth employed by Buckle since June 1989, previously Vice President of Sales and Strategy.
• ·Operates 441 retail stores in 42 states.

09-04-2026

Cardiff Oncology, Inc. (Nasdaq: CRDF) appointed Mani Mohindru, PhD, as permanent President and Chief Executive Officer effective from her prior interim role, Josh Muntner as Chief Financial Officer effective April 6, 2026, and Ajay Aggarwal, MD, MBA, as Chief Operating Officer effective April 27, 2026, to bolster leadership for advancing onvansertib in RAS-mutant metastatic colorectal cancer. Mr. Muntner received an inducement grant of non-qualified stock options to purchase 486,650 shares at $1.58 per share, vesting over four years. These hires bring extensive biopharma experience, including Mr. Muntner's track record raising $86 million at Imvax and approximately $300 million at Mesoblast.

• ·Stock option vests 25% after 12 months and remaining shares monthly over 36 months, subject to continued employment.
• ·Josh Muntner serves on the Board of Directors at Devonian Health Group Inc.
• ·Ajay Aggarwal is a board-certified Pulmonary, Critical Care and Sleep Medicine physician and Fellow of the American College of Chest Physicians.

09-04-2026

On April 6, 2026, Richard E. Byrd, Executive Vice President and President of Becton Dickinson and Company's (BD) Interventional segment, informed the company of his intention to retire and will remain in his role through June 2026. BD intends to name a successor prior to his retirement date. A press release regarding this matter was issued on April 9, 2026, and furnished as Exhibit 99.1.

• ·Filing reported under Items 5.02, 7.01, and 9.01 of Form 8-K.

09-04-2026

NSTS Bancorp, Inc. announced the passing of Nathan E. Walker, Chief Executive Officer and President of North Shore Trust and Savings and Executive Vice President of the Company, who had served in those roles since 2022 after starting as a teller in 1996. Stephen G. Lear, current Chairman, President, and CEO of the Company since 2012, has been appointed CEO and President of the Bank, a role he previously held from 1997 to 2022. As of December 31, 2025, North Shore Trust and Savings reported total assets of $266.6 million.

• ·North Shore Trust and Savings has operated for over 100 years serving local communities in Waukegan and Lindenhurst, Illinois.
• ·Mr. Walker began his career at the Bank as a teller in 1996.
• ·Mr. Lear has served as a director since 2003 and Chairman of both the Company and Bank since 2012.

09-04-2026

Miami International Holdings, Inc. (MIAX) announced the passing of Murray Stahl, a valued member of its Board of Directors, with the earliest event reported on April 7, 2026. The company expressed gratitude for Mr. Stahl's dedication and service. The announcement was made via Form 8-K filed on April 9, 2026, under Item 5.02.

• ·Registrant incorporated in Delaware with Commission File Number 001-42805 and IRS Employer Identification Number 26-1482385.
• ·Principal executive offices at 7 Roszel Road, Suite 1A, Princeton, New Jersey 08540.
• ·Common stock, $0.001 par value per share, traded under symbol MIAX on the New York Stock Exchange.

09-04-2026

On April 3, 2026, Karen Webster resigned from Sezzle Inc.'s Board of Directors, effective immediately, citing growing differences in perspective with management on the company's direction, key decisions, and governance; she served on the Audit and Risk, Compensation, and Nominating and Corporate Governance Committees. On April 9, 2026, the Board appointed Bryan Hunt, an experienced financial services professional and former top-ranked analyst at Wells Fargo, as an independent director to fill the vacancy, assigning him to the same three committees. Mr. Hunt will receive standard non-employee director compensation, including a $65,000 annual Board retainer (prorated) and 935 prorated restricted stock units vesting over approximately 3.7 years.

• ·Bryan Hunt, age 57, spent over 24 years at Wells Fargo in high yield and equity research, recognized as top food and beverage high yield analyst for seven years and top high yield analyst overall in 2016.
• ·Mr. Hunt holds honors from Vanderbilt University – Owen Graduate School of Management and the University of Alabama, and the Chartered Financial Analyst designation.
• ·No arrangements or understandings between Mr. Hunt and any other person for his selection as director; no disclosable transactions under Item 404(a) of Regulation S-K.
• ·Mr. Hunt entered into standard director indemnification agreement.

09-04-2026

Jackson Financial Inc. (NYSE: JXN) announced on April 9, 2026, the appointment of Chris Raub as President and Chief Executive Officer of PPM America, Inc., its indirect wholly-owned subsidiary. Raub, with 27 years of experience at PPM and Jackson including prior roles as President of Jackson National Life Insurance Company and Chief Risk Officer, will oversee PPM's executive team to deliver investment performance for clients including Jackson's general account assets. PPM manages $93.73 billion in assets under management as of December 31, 2025.

• ·PPM America offers investment capabilities in public fixed income, commercial real estate debt, private and structured credit, private equity, and CLO management.
• ·AUM includes committed but unfunded capital for PPM’s private equity and commercial real estate businesses, as well as securities issued by PPM CLO vehicles and underlying collateral assets.

09-04-2026

TPG Inc. announced the appointment of Admiral William H. McRaven as an independent director to its Board of Directors, effective May 1, 2026. McRaven, a retired U.S. Navy Four-Star Admiral with over four decades of experience in public and private sectors, currently serves as a Senior Advisor at Lazard, Inc. and Professor of National Security at the University of Texas at Austin. TPG, a leading global alternative asset management firm founded in 1992, manages $303 billion of assets under management.

• ·McRaven serves on the board of directors of ConocoPhillips and the advisory board of Haveli Investments.
• ·McRaven also serves on boards including Council on Foreign Relations, National Football Foundation, International Crisis Group, and The Mission Continues.
• ·McRaven was formerly Chancellor of the University of Texas System.
• ·Filing date: April 09, 2026

09-04-2026

CEA Industries Inc. (NASDAQ: BNC) announced inducement grants of 363,636 restricted stock units (RSUs) to Brent Miller, its newly appointed Chief Financial Officer effective March 9, 2026, under the CEA Industries Inc. 2026 Inducement Plan, pursuant to Nasdaq Listing Rule 5635(c)(4). The RSUs vest with 25% on the first anniversary of the grant date and the remaining 75% in equal quarterly installments through the fourth anniversary, subject to Mr. Miller's continued employment. No other financial performance metrics or period-over-period comparisons were disclosed.

• ·Grants comply with Nasdaq Listing Rule 5635(c)(4) as inducement for new hires or re-hires after non-employment period.
• ·Announcement dated April 8, 2026; SEC filing April 9, 2026.

09-04-2026

CarMax announces the addition of William Cobb and Jim Kessler as new directors ahead of its 2026 Annual Meeting of Shareholders, following constructive engagement with activist investor Starboard Value LP, which has agreed to withdraw its director nominations. The new directors bring over 30 years and 20 years of leadership in consumer/tech and automotive sectors, respectively, strengthening the Board's expertise amid leadership transition with Keith Barr as new CEO. FY2025 highlights include sales of approximately 790,000 used vehicles and 540,000 wholesale vehicles, with CarMax Auto Finance originating more than $8 billion in loans and maintaining a nearly $18 billion portfolio across more than 250 stores and over 28,000 associates.

• ·Filing date: April 09, 2026
• ·New directors to join in connection with 2026 Annual Meeting of Shareholders
• ·CarMax recognized for 22 consecutive years as one of the Fortune 100 Best Companies to Work For

09-04-2026

BayCom Corp announced a major leadership transition effective April 13, 2026, appointing William J. Black, Jr. as Executive Vice Chairman, Christopher F. Baron as CEO, and Kevin L. Thompson as CFO, leveraging their experience from larger institutions to address an organic growth gap and pursue larger acquisitions after four years of a quiet pipeline. Outgoing founders George J. Guarini, Janet L. King, and Keary L. Colwell, who led 10 mergers over 22 years, are resigning from executive roles and the board (effective April 10, 2026), leaving a clean balance sheet and strong credit quality but a trading multiple not fully reflecting value. The transition includes board reconstitution with new directors and continuity from key executives like Chief Credit Officer Terry Curley.

• ·Incoming executives join Company and Bank boards effective April 13, 2026.
• ·George J. Guarini continues on Bank board post-resignation for continuity.
• ·Outgoing executives receive separation payments per existing agreements (one-time, non-recurring).
• ·90-day notice period for orderly handover before outgoing executives' employment ends.
• ·Bank founded in 2004; operates in California, Washington, New Mexico, Colorado, Nevada.

09-04-2026

On April 4, 2026, Green Stream Holdings, Inc. accepted the resignation of all prior directors and officers, immediately appointing Nan Yang as the sole Director and Officer, serving in all capacities including CEO, CFO, Secretary, and Treasurer. The Company also abandoned its previously disclosed pursuit of a potential acquisition of Law90 due to internal strategic considerations, with no definitive alternative agreements in place.

• ·No family relationships between Nan Yang and former directors/officers.
• ·No arrangements or understandings pursuant to Nan Yang's appointment.
• ·No material plans, contracts, or arrangements with Nan Yang requiring Item 404(a) disclosure.

09-04-2026

On April 5, 2026, Jonathan J. Hastings, Senior Vice President, M&A and Strategy of Minerals Technologies Inc., notified the company that he will step down from that position effective April 30, 2026. Mr. Hastings will continue to serve the company as Corporate Strategy Advisor to the Chairman and Chief Executive Officer. The filing was signed by Timothy J. Jordan, Vice President, General Counsel, Secretary and Chief Compliance Officer, on April 9, 2026.

09-04-2026

Novocure GmbH assigned Uri Weinberg the additional role of Chief Medical Officer concurrent with his existing Chief Innovation Officer responsibilities, effective via a letter agreement dated April 7, 2026. In recognition, he will receive a monthly stipend of CHF 5,000 (gross) for the duration of the assignment, excluded from annual incentive payment calculations. All other employment terms remain unchanged.

• ·Agreement signed April 8, 2026 by both parties
• ·Stipend solely for additional CMO assignment and not included in AIP calculations
• ·Filed as SEC 8-K on April 09, 2026 under Items 5.02 and 9.01

09-04-2026

On April 7, 2026, the Compensation Committee of Adial Pharmaceuticals, Inc. approved restricted stock awards (RSAs) to named executive officers and directors under the 2017 Equity Incentive Plan, including 37,985 RSAs to CEO Cary Claiborne, 17,325 to CFO Vinay Shah, and 26,510 to COO Tony Goodman. Additional RSAs of 9,185 each were granted to directors Kevin Schuyler and Robertson H. Gilliland, while director Kermit Anderson received options for 9,185 shares at $1.64 per share. All awards vest in full on the one-year anniversary of the grant date or upon a Change of Control.

• ·RSAs are subject to forfeiture upon cessation of service if vesting conditions not met.
• ·A form of Restricted Stock Award Agreement was approved by the Board and filed as Exhibit 10.1.

09-04-2026

On April 2, 2026, Robert D’Agostino, a member of BRC Group Holdings, Inc.'s Board of Directors (formerly B. Riley Financial, Inc.), informed the company that he will not stand for re-election at the 2026 annual meeting of stockholders. Mr. D’Agostino will continue serving on the Board and his current committees until the end of his term at the Annual Meeting. His decision was not due to any disagreement with the company on operations, policies, or practices.

• ·Annual meeting of stockholders scheduled for 2026.
• ·Company address: 11100 Santa Monica Blvd., Suite 800, Los Angeles, CA 90025.
• ·SEC File Number: 001-37503; CIK: 0001464790; EIN: 27-0223495.

09-04-2026

Solana Company (NASDAQ: HSDT) appointed Madelene Gani, CPA, as Chief Operating Officer and Deputy Chief Financial Officer, effective April 6, 2026, to lead operational scaling, treasury optimization, revenue diversification, and institutional infrastructure buildout for the Solana ecosystem. Gani brings over 25 years of experience from transformative roles at Hedera Hashgraph (CFO/COO), Aptos Labs (Head of Finance), Gemini (global finance transformation amid $7.1B valuation), and JUUL Labs (IPO readiness and expansions). Joseph Chee, Executive Chairman, highlighted her expertise in driving financial discipline and growth for Solana's next super cycle.

• ·Appointment effective April 6, 2026
• ·Gani's prior achievements include millions in annualized savings at Hedera Hashgraph and leading Gemini's expansion to Asia Pacific and Europe
• ·Gani holds a Bachelor of Business Administration from the University of San Diego

09-04-2026

Plus Therapeutics, Inc. (PSTV) announced the appointment of Dr. Eric J. Daniels, M.D., age 53, as Chief Development Officer, effective April 20, 2026, to oversee the development and approval of the company's pharmaceutical pipeline. Dr. Daniels brings extensive biotech experience, including as Chief Development Officer at Kiora Pharmaceuticals (NASDAQ:KPRX) from October 2021 to April 2026. Compensation includes an initial annual base salary of $460,000, a 40% target bonus, 20,000 stock options vesting over four years, and 20,000 RSUs vesting over three years, both with a one-year cliff.

• ·Stock options have exercise price equal to fair market value on grant date and vest monthly over four years with one-year cliff.
• ·RSUs vest quarterly over three years with one-year cliff.
• ·Involuntary termination severance includes 12 months base salary, target bonus, prior year bonus (if applicable), and 12 months COBRA premiums, plus 9 months accelerated vesting of Stock Awards.
• ·No family relationships or material interests under Item 404(a) of Regulation S-K.

09-04-2026

Science Applications International Corp (SAIC) appointed Paul Eremenko and Admiral Michael Rogers, USN Retired, as new members of its Board of Directors effective April 8, 2026, increasing the board size from eleven to thirteen members; both will serve on the Audit Committee and Technology Committee until the 2026 Annual Meeting. Mr. Eremenko brings expertise in AI, aerospace, and advanced engineering from roles at P-1 AI, Universal Hydrogen, UTC/RTX, Airbus, Google, and DARPA. Adm. Rogers offers deep experience in cybersecurity, intelligence, and national security from his tenure as Director of the NSA and Commander of U.S. Cyber Command.

• ·New directors entitled to standard non-employee director cash and equity compensation, pro-rated to 2026 Annual Meeting, and participation in Deferred Compensation Plan.
• ·No arrangements or understandings pursuant to which appointees were selected.
• ·No relationships or related transactions required to be reported under Item 404(a) of Regulation S-K.

09-04-2026

Lineage, Inc. announced the planned retirement of Chief Information Officer and Chief Transformation Officer Sudarsan Thattai in April 2027, with a phased transition where day-to-day IT leadership shifts to Vice President of Technology Projects Chris Johnson, while Thattai focuses on high-impact priorities. Thattai, who joined in 2013, developed key technologies like LinOS and will support the transition. The announcement emphasizes a smooth handoff to maintain momentum in IT initiatives.

• ·Transition period extends through April 2027
• ·Lineage operates in North America, Europe, and Asia-Pacific
• ·Investor Relations contact: ir@onelineage.com
• ·Media contact: pr@onelineage.com

09-04-2026

Jennifer M. Daniels, who has served as Chief Legal Officer and Secretary of Colgate-Palmolive Company since 2014, announced her intention to retire in 2026. On April 8, 2026, the Board elected Betsy Fishbone, currently Executive Vice President and Deputy Chief Legal Officer, as the new Chief Legal Officer and Secretary effective June 1, 2026. Simultaneously, Daniels was elected to Vice Chair to facilitate an orderly transition.

• ·Date of earliest event reported: April 8, 2026
• ·Filing date: April 9, 2026

09-04-2026

Pulse Biosciences, Inc. (Nasdaq: PLSE) appointed Liane Teplitsky as Chief Operating Officer and expanded Dr. David Kenigsberg’s role to full-time Chief Medical Officer on April 9, 2026, to enhance strategic alignment for the nPulse Cardiac Catheter Ablation System development and commercialization. Ms. Teplitsky, with prior CEO role at Artedrone and leadership at Abbott Laboratories, St. Jude Medical, and Zimmer Biomet, received inducement awards including a stock option for 700,000 shares at $19.06 per share and 200,000 RSUs. These changes position the company to accelerate clinical, regulatory, and commercial objectives without reported setbacks.

• ·Inducement awards to Ms. Teplitsky approved April 8, 2026, under 2017 Inducement Equity Incentive Plan per Nasdaq Rule 5635(c)(4).
• ·Start Date Option vesting: 200,000 shares time-based (25% annually over 4 years), 500,000 performance-based (market cap and revenue milestones).
• ·Start Date RSUs vest on similar performance objectives.
• ·Dr. Kenigsberg maintains active clinical practice while expanding CMO role.
• ·Ms. Teplitsky retains Chairman role at Carvolix (Paris-EUR).

09-04-2026

On April 6, 2026, Krista McDonough, Chief Legal and Sustainability Officer of Capri Holdings Limited, notified the company of her voluntary resignation effective June 26, 2026, to pursue another professional opportunity. The company has initiated a process to identify her successor. The filing was made on April 9, 2026.

09-04-2026

AeroVironment, Inc. (AVAV) announced the appointment of Dr. Robert (Rob) Smith as Executive Vice President and Chief Operating Officer, effective April 13, 2026, to oversee Autonomous Systems (AxS), Space, Cyber and Directed Energy (SCDE) business units, global operations, and manufacturing amid rising customer demand. Dr. Smith joins from Raytheon, where he led a multi-billion-dollar radar and electronic warfare business, bringing extensive experience from CAES, BWX Technologies, Lockheed Martin, and other roles. CEO Wahid Nawabi highlighted Smith's track record in driving performance to support AV's scaling efforts.

• ·Dr. Smith holds a bachelor’s degree (Cum Laude) in chemical engineering from the University of Maryland Baltimore County, a Ph.D. in chemical engineering from Auburn University, and an MBA from Johns Hopkins University.
• ·Appointment reflects focus on scaling manufacturing to meet rising customer demand in a dynamic global defense environment.